EN IT

AstraZeneca stock falls 4.1% on the week, with the buy signal now in week 4. The first of the model's 3 references was reached this week; the model indicates a full position size and sets the next scaling-out window in week 6.

AstraZeneca -4.1%: buy signal in week 4 reaches the model's first reference
Buy signal in progress, first reference reached

AstraZeneca -4.1%: buy signal in week 4 reaches the model's first reference

November 20, 2026

Our view last week

AstraZeneca stock edges up 0.4%, and the buy signal, now in week 3, stands 9.03% above entry. For anyone weighing an entry, our model points to a standard position size. The next scaling-out window falls in week 6, for 10% of the position.

This week's summary

AstraZeneca stock falls 4.1% on the week, while the buy signal, now in week 4, is still 4.59% up since entry. Our model reads the signal as one with a wide expected move. The first of its 3 references was reached this week, and the next scaling-out window, for 10%, comes in week 6. For a new entry, the model points to a full position size.
Disclaimer. Technical analysis and personal opinion of the author, not financial advice or a personalised recommendation. The author may hold positions in the instruments analysed. Read more ▾Close ▴
Disclaimer — The content on this page is published for educational and informational purposes and represents the author's personal opinion and technical analysis. It is not financial advice, a solicitation to invest, or personalised recommendation. Trading financial instruments involves significant risks and may result in the loss of all or part of the invested capital. Every operational decision is the sole responsibility of the user, who acknowledges acting in full autonomy and full awareness of risk. The author may hold, open or close positions in the instruments analysed, including positions opposite to the analysis, before or after publication, with no obligation to disclose them.
Become a Platinum client to read the full technical analysis, the trading plan and the detailed entry, take-profit and stop-loss levels. 15-day free trial. ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn